Home / Healthcare / External Defibrillator Market

External Defibrillator Market Size, Share and Industry Analysis By Product (Automated External Defibrillator (AED), Manual and Semi-automatic External Defibrillator, Wearable External Defibrillator), By End User (Hospitals & Clinics, Schools and other Public Places), and Regional Forecast 2019-2032

Report Format: PDF | Latest Update: Apr, 2024 | Published Date: Jul, 2019 | Report ID: FBI100949 | Status : Published

The global external defibrillator market size stood at USD 3,152.5 million in 2018 and is projected to reach USD 11,430.0 million by 2032, exhibiting a CAGR of 9.7% during the forecast period (2018-2032).


An external defibrillator is a portable electronic device that is utilized to detect and treat cardiac arrhythmia (pulseless ventricular tachycardia and ventricular fibrillation) with the help of electric impulses. Rapidly growing prevalence of sudden cardiac arrests, increasing product awareness amongst population and benefits offered by external defibrillators are expected to boost the adoption of external defibrillators during the forecast period.



According to a research conducted by the Sudden Cardiac Arrest Foundation (SCAF) in 2018, an estimated 356,000 people suffer from out-of-hospital cardiac arrest (OHCA) each year in the U.S. Moreover, increasing prevalence of congenital heart disease, obesity, diabetes, smoking, and high blood pressure are expected to boost the prevalence of sudden cardiac arrest, which can result into increased adoption of external defibrillators during the forecast period. 


"Superior Ergonomics and Effective Treatment Outcomes of Wearable defibrillator are Expected to Boost the External Defibrillator Market Share and Growth "


In 2014, Asahi Kasei Corporation launched LifeVest, a wearable defibrillator in certain parts of the world. A wearable external defibrillator is programmed in such a way that; it can predict the risk of sudden cardiac arrest even before it occurs. Combined with this, automatic shock delivery with an aim to restore the heart rhythm and cost-effectiveness are anticipated to offer a favorable environment for the adoption of wearable defibrillators. At present, the availability of wearable external defibrillator is limited to certain countries. However, the projected global launch of wearable defibrillator by Asahi Kasei Corporation serves huge opportunity for the global external defibrillator market growth owing to benefits offered by the wearable defibrillator. Among the products, a wearable external defibrillator is expected to be the fastest-growing segment globally.


Market Segmentation


On the basis of product, the global external defibrillator market report includes segments as automated external defibrillator, manual & semi-automated external defibrillator and wearable external defibrillator. An automated external defibrillator held an estimated 45.9% in the global external defibrillator market share in 2018, owing to increasing adoption, favorable government regulations, and minimal costs. 



In terms of end users, the public places and others are expected to register comparatively higher global market share owing to higher installations of automated external defibrillators (AEDs) in developed as well as emerging nations.


Regional Analysis


"Higher Adoption of External Defibrillator Installations Across the U.S. Enables Market to Hold Considerable Share in North America"


North America generated a revenue of US$ 1,690.6 Mn in 2018 and is expected to dominate the market throughout the forecast period. Growing installations of external defibrillators in hospitals, as well as public places such as schools, hotels, streets, railway stations, and others with an aim to prevent fatalities from sudden cardiac arrest, is prominently driving the growth of the North America external defibrillator market.



Moreover, favorable government regulations, the growing emphasis on AED training, and increasing awareness amongst people to treat out-of-hospital cardiac arrest are projected to boost the external defibrillator market sales in North America.


Key Market Drivers


"Asahi Kasei Corporation and Philips Healthcare to Hold More Than Half of the Market Share in Terms of Revenue"


Asahi Kasei Corporation is a leading player in the global external defibrillator market. The company is estimated to retain its position in the forecast duration owing to its diverse product offering in external as well as wearable defibrillator segment, efficient customer reach, and strong after-sales service. This company, together with Philips Healthcare, currently holds over half of the market share in terms of revenue. Other players operating in the global external defibrillator market are Cardiac Science, Physio Control, Stryker, Defibtech, LLC., CU Medical Systems Inc., and others.


List of Companies Profiled



  • Asahi Kasei Corporation

  • Philips Healthcare

  • Defibtech, LLC.

  • Cardiac Science

  • Stryker

  • CU Medical System Inc.

  • Other prominent players


Key Industry Developments:



  • April 2021 – ZOLL Medical Corporation, an Asahi Kasei company, announced that the company had acquired Respicardia, Inc, a provider of implantable neurostimulators for treating moderate to severe Central Sleep Apnea (CSA). CSA is a severe condition often associated with heart failure, coronary artery disease, and certain cardiac arrhythmias.

  • July 2020 - ZOLL Medical Corporation, an Asahi Kasei Group company, announced its new remote view technology on the X Series defibrillator developed for EMS agencies. It permits clinician to view the X Series screen remotely at the time of patient monitoring.

  • June 2020 - Philips, a worldwide leader in health technology announced that company has received the premarket approval for HeartStart FR3 and HeartStart FRx automated external defibrillators (AEDs) from the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA).


Report Coverage



External defibrillator offers an effective treatment option to deal with out-of-hospital cardiac arrest and arrhythmia. Automated external defibrillators detect arrhythmia and restore the patient’s heartbeats which can lead to fatal death. The rapidly increasing prevalence of out-of-hospital cardiac arrests and unmet demand in emerging nations along with favorable government regulations are expected to drive the global external defibrillator market revenue by 2026. 


The report provides qualitative and quantitative insights on the external defibrillator industry trends and detailed analysis of market size and growth rate for all possible segments in the market. The external defibrillator market segments include product, end-user, and region. On the basis of the product, the market is segmented into an automated external defibrillator (AED), manual and semi-automatic external defibrillator, and wearable external defibrillator.


Various end-users covered under the report are hospitals & clinics and schools and other public places. Geographically, the global market is segmented into four major regions, which are North America, Europe, Asia Pacific, and the rest of the World. The regions are further categorized into countries. 


Along with this, the report analysis provides an elaborative analysis of the global external defibrillator market dynamics and competitive landscape. Various key insights provided in the report are the prevalence of sudden cardiac arrests in key countries, technological advancements in external defibrillators industry, recent industry developments in the global market, such as mergers & acquisitions, the regulatory scenario in key countries, new products launches, reimbursement scenario, and key industry trends.


SEGMENTATION






















 ATTRIBUTE



 DETAILS



By Product




  • Automated External Defibrillator (AED)

  • Manual and Semi-Automatic External Defibrillator

  • Wearable External Defibrillator



By End User




  • Hospitals & Clinics

  • Schools and other Public Places



By Geography




  • North America (USA and Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

  • Rest of the World


Frequently Asked Questions

How much is the Global External Defibrillator market worth?

Fortune Business Insights says that the Global External Defibrillator market was valued at USD 3,152.5 Million in 2018 and is projected to reach USD 6,463.0 Million by 2026.

What was the value of the Global External Defibrillator Market in 2018?

In 2018, the market was valued at USD 3,152.5 Million.

At what CAGR is the Global External Defibrillator market projected to grow in the forecast period (2019-2026)?

Growing at a CAGR of 9.4%, the market will exhibit steady growth in the forecast period (2019-2026)

What is the leading segment in the Global External Defibrillator market?

Automated External Defibrillator is expected to be the leading segment in this market during the forecast period.

What is the key factor driving the Global External Defibrillator market?

Superior ergonomics and effective treatment outcomes of wearable defibrillator will drive the growth of the Global External Defibrillator market.

Which region dominated the Global External Defibrillator market in 2018?

North America dominated the Global External Defibrillator market in 2018?

Who are the top players in Global External Defibrillator market?

Asahi Kasei Corporation and Philips Healthcare are the top players in the market.

Which factors are expected to drive the growth of Automated External Defibrillators Market segment?

Increasing adoption, favorable government regulations, and minimal costs of Automated External Defibrillator is estimated to drive the market.

What are the Global External Defibrillator market trends?

Increasing shift towards adoption of wearable external defibrillator owing to the added benefits offered by the products are one the key trends of Global External Defibrillator Market.

  • Global
  • 2018
  • 2015-2017
  • 112
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Buy Now

Healthcare Clients